NUVB

Nuvation Bio Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$4.06

Price (1 Year)

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %40.3 / %30

Non-compliant assets / Total market cap %50.8 / %30

Non-compliant revenue / Total income %9 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the treatment of patients with ROS1+ non-small cell lung cancer.

Website

Analysis (Turkish): NUVB Hissesi Caiz mi, Helal mi? Nuvation Bio Inc. Katılım Analizi